Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of ...

No neurofibrillary tangles or amyloid plaques were found in the parenchyma ... magnetic gait and hypertonia of the extremities, treatment with dexamethasone (2 × 4 mg/day) was started.

The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /EINPresswire / -- The market for cerebral amyloid angiopathy treatment has been steadily growing. It is ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help ... people with underlying ...

The publication, titled N-Acetylcysteine for hereditary cystatin C amyloid angiopathy (HCCAA), a nonrandomised clinical trial, details a new treatment approach for HCCAA, a rare and fatal genetic ...

Panelists discuss how hesitancy in prescribing amyloid-targeting therapies stems from multiple factors including concerns ...

Meta-analysis did not show a statistically significant difference in the levels of tau in the cerebrospinal fluid of people with cerebral amyloid angiopathy and people with Alzheimer's disease (effect ...

These results corroborate clearance of amyloid-β deposits after initial treatment of the cortex with direct application of 10D5. Figure 4: Histological analysis of imaged brains from 20-month-old ...

Histological examination shows amyloid-laden vessels and the appearance ... appears to derive a beneficial effect from corticosteroid treatment. This effect could be dependant on the pathological ...